Truist Securities Maintains Hold on Bausch Health Companies, Lowers Price Target to $7
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Gregory Fraser maintains a Hold rating on Bausch Health Companies (NYSE:BHC) and lowers the price target from $8 to $7.
July 25, 2024 | 2:25 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Truist Securities analyst Gregory Fraser maintains a Hold rating on Bausch Health Companies (NYSE:BHC) and lowers the price target from $8 to $7.
The lowered price target from $8 to $7 by Truist Securities suggests a negative outlook on Bausch Health Companies' stock performance, likely leading to a short-term decline in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100